Valuation EUROAPI OTC Markets

Stocks

Delayed OTC Markets Other stock markets 04:58:08 16/06/26 am AEST			5-day change	1st Jan Change
1.510 ^USD	-2.58%		-.--%	-42.59%

30/07	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026
30/07	Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,302	543.9	274.4	216.1	91.09	-	-
Change	-	-58.23%	-49.55%	-21.22%	-57.85%	-	-
Enterprise Value (EV) ¹	1,348	734.9	270.5	167.7	192.1	149.9	169.3
Change	-	-45.5%	-63.2%	-37.98%	14.55%	-21.98%	12.97%
P/E	-86.6x	-2.84x	-2.09x	-1.02x	-0.53x	-1.9x	-9.7x
PBR	1.17x	0.59x	0.28x	0.27x	0.15x	0.14x	0.14x
PEG	7.8x	-0x	0.1x	-0x	0x	0x	0.1x
Capitalization / Revenue	1.33x	0.54x	0.3x	0.25x	0.12x	0.12x	0.12x
EV / Revenue	1.38x	0.73x	0.3x	0.2x	0.25x	0.2x	0.22x
EV / EBITDA	11.2x	7.89x	5.37x	2.53x	4.37x	2.57x	2.51x
EV / EBIT	28.5x	44x	-10.2x	-2.26x	-2.32x	-14.5x	-44.7x
EV / FCF	-11x	-5.75x	18.2x	3.35x	-2.21x	-7.89x	-11.1x
FCF Yield	-9.09%	-17.4%	5.51%	29.8%	-45.2%	-12.7%	-8.98%
Dividend per Share ²	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-
EPS ²	-0.16	-2.02	-1.38	-2.23	-1.8	-0.503	-0.0987
Distribution rate	-	-	-	-	-	-	-
Net sales ¹	976.6	1,013	911.9	848.2	756.3	763.2	784.3
EBITDA ¹	120	93.1	50.4	66.2	43.95	58.33	67.41
EBIT ¹	47.3	16.7	-26.4	-74.3	-82.8	-10.35	-3.788
Net income ¹	-15	-189.7	-130.6	-211.2	-170.8	-47.98	-9.285
Net Debt ¹	46.3	191	-3.9	-48.4	101	58.81	78.25
Reference price ²	13.8500	5.7300	2.8800	2.2700	0.9570	0.9570	0.9570
Nbr of stocks (in thousands)	94,010	94,913	95,263	95,214	95,188	-	-
Announcement Date	8/3/23	28/2/24	3/3/25	3/3/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.19x	11.9x	25x	0.6%	1T
JOHNSON & JOHNSON	27.59x	6.24x	17.41x	2.11%	613B
ABBVIE INC.	33.42x	7.23x	14.91x	2.82%	433B
ROCHE HOLDING AG	19.84x	4.71x	11.66x	2.81%	350B
NOVARTIS AG	21.78x	5.64x	14.07x	2.85%	292B
ASTRAZENECA PLC	19.76x	4.1x	11.62x	2.15%	239B
NOVO NORDISK A/S	13.29x	4.98x	10.27x	3.76%	206B
AMGEN INC.	24.88x	6.52x	11.5x	2.66%	204B
GILEAD SCIENCES, INC.	-47.26x	5.67x	31.29x	2.51%	163B
Average	16.39x	6.33x	16.42x	2.48%	388.94B
Weighted average by Cap.	23.92x	7.55x	17.90x	2.05%